secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENZO BIOCHEM INC (—)
CIK:        0000316253
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001213900-24-064752
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Mary Tagliaferri resigns from Enzo Biochem board, effective Aug 6, 2024
--------------------------------------------------------------------------------

- Mary Tagliaferri, M.D., resigned from the Board, effective August 6, 2024, to pursue other opportunities.
- Resignation was not due to any disagreement with the Company on operations, policies, or practices.
- Company has commenced a search for a replacement director to fill the vacancy.
- Board expressed gratitude for Dr. Tagliaferri's service and contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/316253/000121390024064752/0001213900-24-064752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/316253/000121390024064752/ea021050901-8k_enzobio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-064752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer